In 2022, there were up to 1.2 million people with HIV (PWH) and 37,981 new cases of HIV in the United States alone. 1 While ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a ...

Since the first reported case of HIV in the U.S. 43 years ago, ending HIV epidemic is possible with new medicine that may ensure long, healthy lives and prevention.

Dr. John Nkengasong outlines three priorities to sustain and accelerate progress. First, ensure that those receiving ...

Although sexually transmitted infections are still at an epidemic level in the US, scientists at the US Centers for Disease ...